Food Allergy News and Research

Half of Kids Who Needed Epinephrine Didn’t Get It Before Trip to the Emergency Room

[PRESS RELEASE] Study shows parents, guardians and emergency responders failed to give epinephrine at home. ARLINGTON HEIGHTS, IL (July 12, 2017 – 12:01 am ET) – Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn’t receive the life-saving medication when they needed it. The study in Annals of Allergy, Asthma and Immunology , the scientific...

Adamis Pharmaceuticals' Epinephrine Pre-Filled Syringe Receives FDA Approval

Adamis Pharmaceuticals Corporation announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ EPINEPHRINE INJECTION, USP, 1:1000 (0.3 mg Pre-filled single dose syringe) (“PFS”) for the emergency treatment of allergic reactions (Type I) including anaphylaxis. The FDA has also approved the PFS trade name of Symjepi™.

Kmart® Pharmacy Lowers Cost of Generic Epinephrine Auto-injector Pens

[Press Release] Kmart® Pharmacy Lowers Cost of Generic Epinephrine Auto-injector Pens SOURCE Kmart $0 Copays Attainable for Commercially Insured Patients HOFFMAN ESTATES, Ill. , April 25, 2017 /PRNewswire/ -- In response to the massive increase in the cost of epinephrine auto-injector pens, Kmart Pharmacy lowered the cost of the generic version of Adrenaclick (epinephrine injection, USP auto-injector) as low as $0 for commercially insured patients* and $199.99 for cash paying patients per...

Aimmune Therapeutics Reports Positive Results From Peanut Immunotherapy Studies

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, announced clinical data presented today at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Atlanta. The presentations included Phase 3 screening data and Phase 2 adherence data from Aimmune’s AR101 program. AR101 is Aimmune’s investigational biologic oral immunotherapy for desensitization of patients with peanut allergy.

New Allergy and Anaphylaxis Action Plan

The American Academy of Pediatrics (AAP) reaffirmed epinephrine as the first choice to treat severe allergic reactions. And to make certain parents, caregivers and others are ready to treat anaphylaxis, the AAP released its own version of a food allergy action plan . 1 Download PDF The recommendations were released in the February 13 edition of the journal Pediatrics . 2 The report stresses that it is better to use epinephrine early, even if parents are not 100% sure that the symptoms are...

NJ Residents: Contact Your Local Representatives About Elemental Formula Bill

If you live in New Jersey, take action now by urging your local representative in the New Jersey state legislature to move a bill through the legislative process that covers the cost of special formula for eosinophilic disorders regardless of delivery method. The bill, S2649, gives health insurance coverage for amino acid-based elemental formulas (like Neocate® or EleCare®) for eosinophilic disorders. The bill provides coverage for elemental formula no matter how it is delivered. An infant...

AUVI-Q® Epinephrine Auto-Injectors Now Available Through Direct Delivery

People at risk for anaphylaxis can begin ordering AUVI-Q® epinephrine auto-injectors today through Kaléo’s direct delivery service. According to the company, it is also launching its AUVI-Q Afford Ability ™ program: People with commercial insurance will have an out-of-pocket cost of $0 - even if their insurance company will not cover AUVI-Q. That also applies to those with high-deductible plans. For patients who do not have government or commercial insurance, and have a household income of...

Help Drive the Future of Food Allergy Research

Does your family have food allergies? If so, we invite you to inform food allergy research. Our Food Allergy Patient & Family Registry (Registry) is a web-based program that gives you a place to share your experiences. The Registry is a program to collect, manage and analyze data from and about people with food allergies. It will advance research through patient information. Our goal is to find ways to prevent and cure food allergy. The first and only “patient-centered” food allergy...

What Are Your Options for Epinephrine Auto-Injectors?

Epinephrine is a lifesaving medicine for people with severe allergies. It’s awful to think that some Americans have to choose between putting food on the table and putting an epinephrine auto-injector in their child’s backpack. It is important to discuss with your physician about what is the most appropriate prescription for your family. You may also need to find out which options your insurance provider prefers. This will affect your out-of-pocket costs. Each device has its own unique set...

WEBINAR: Reducing Risk of Peanut Allergy – A Review of New Guidelines

New guidelines released in 2017 may help prevent the development of peanut allergy. The guidelines recommend early introduction of peanut-containing foods to infants as early as 4 and 6 months of age. How peanut-containing foods should be introduced to infants depends on the infant’s risk level. Join us for a free webinar on January 26, 2017 at 3 pm EST.